Skip to Content
Last Updated: 04/25/2012

The NIH Pharmacogenomics Research Network

The Pharmacogenomics Research Network (PGRN), funded since 2000, is a network of scientists focused on understanding how a person’s genes affect his or her response to medicines. The network is co-funded with the National Institute of General Medical Sciences (NIGMS), with NIGMS as the primary institute.

About the
Associate Director

Jeffrey S. Abrams, M.D. Jeffrey S. Abrams, M.D., has led the Cancer Therapy Evaluation Program (CTEP) since June 2007.  Dr. Abrams came to CTEP in 1993 when he joined as a clinical research scientist to oversee the breast cancer treatment trials portfolio and participate in clinical trials at the NIH Clinical Center and the National Naval Medical Center. More…

For More Details
About CTEP